Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

维尔达格利普汀 二甲双胍 医学 安慰剂 内科学 胰岛素 糖尿病 2型糖尿病 2型糖尿病 人口 胃肠病学 内分泌学 环境卫生 病理 替代医学
作者
Wolfgang Kothny,James E. Foley,Plamen Kozlovski,Q. Shao,Baptist Gallwitz,Valentina Lukashevich
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:15 (3): 252-257 被引量:99
标识
DOI:10.1111/dom.12020
摘要

Aim The aim of this study is to assess the efficacy and safety of vildagliptin 50 mg bid as add‐on therapy to insulin in type 2 diabetes mellitus ( T2DM ). Methods This is a multicentre, double‐blind, placebo‐controlled, parallel group, clinical trial in T2DM patients inadequately controlled by stable insulin therapy, with or without metformin. Patients received treatment with vildagliptin 50 mg bid or placebo for 24 weeks. Results In all, 449 patients were randomized to vildagliptin (n = 228) or placebo (n = 221). After 24 weeks, the difference in adjusted mean change in haemoglobin A1c ( HbA1c ) between vildagliptin and placebo was −0.7 ± 0.1% (p < 0.001) in the overall study population, −0.6 ± 0.1% (p < 0.001) in the subgroup also receiving metformin and −0.8 ± 0.2% (p < 0.001) in the subgroup without metformin. Vildagliptin therapy was well tolerated and had a similarly low incidence of hypoglycaemia compared with placebo (8.4 vs. 7.2%, p = 0.66) in spite of improved glycaemic control, and was not associated with weight gain. (+0.1 vs. −0.4 kg). Conclusions Vildagliptin 50 mg bid added to insulin significantly reduced HbA1c in patients with T2DM inadequately controlled by insulin, with or without metformin. Vildagliptin was well tolerated, with a safety profile similar to placebo. These results were achieved without weight gain or an increase in hypoglycaemia incidence or severity in spite of improved glycaemic control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
牧青完成签到,获得积分20
刚刚
传奇3应助诗音时雨采纳,获得10
1秒前
1秒前
跳跃的乐萱完成签到 ,获得积分10
3秒前
4秒前
爆米花应助1874采纳,获得10
4秒前
可爱的函函应助丢丢采纳,获得10
6秒前
毛菇娘发布了新的文献求助10
7秒前
orixero应助超帅的薯片采纳,获得10
8秒前
麦麦完成签到,获得积分10
10秒前
123发布了新的文献求助10
11秒前
天天快乐应助kuaijack采纳,获得10
12秒前
毛豆应助trans采纳,获得10
14秒前
14秒前
15秒前
科研通AI2S应助闪闪的若烟采纳,获得10
16秒前
16秒前
18秒前
18秒前
19秒前
1874发布了新的文献求助10
21秒前
东方三问发布了新的文献求助10
21秒前
科研通AI2S应助liu采纳,获得10
21秒前
22秒前
zeb完成签到,获得积分10
24秒前
realer发布了新的文献求助10
25秒前
chen应助wei采纳,获得10
25秒前
南海牧鲸人完成签到,获得积分10
26秒前
汉堡包应助雪白凌晴采纳,获得10
26秒前
26秒前
丢丢发布了新的文献求助10
26秒前
robotJ完成签到,获得积分10
26秒前
30秒前
树池完成签到,获得积分10
31秒前
32秒前
洁净的老寿星完成签到,获得积分10
33秒前
超帅的薯片完成签到,获得积分10
33秒前
1874完成签到,获得积分10
34秒前
自然白亦完成签到,获得积分10
34秒前
35秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
New China Forges Ahead: Important Documents of the Third Session of the First National Committee of the Chinese People's Political Consultative Conference 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3056175
求助须知:如何正确求助?哪些是违规求助? 2712737
关于积分的说明 7432964
捐赠科研通 2357715
什么是DOI,文献DOI怎么找? 1249040
科研通“疑难数据库(出版商)”最低求助积分说明 606843
版权声明 596195